Indivior Pharmaceuticals, Inc. (INDV): Free Cash Flow
-$93.00M
Year ended 2025-12-31
-$111.00M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$93.00M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $7.00M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$308.00M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$9.00M | n/a | 2025-03-03, From 2022-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$93.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Alkermes plc. (ALKS) | 2025-12-31 | $480.33M | +18.4% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $9.87M | -76.4% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | -$320.03M | n/m |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $702.34M | n/m |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $171.39M | +258.7% |
Compare INDV, PBH, ACAD, ALKS side by side · Screen every company in Pharmaceutical Preparations ↗